Genentech is soliciting research that can be used to blunt pharma reforms in Washington

Summary: Genentech is offering researchers up to $125,000 to write papers that support the drug industry. They want this research to argue that new pricing rules might hurt future medical inventions. Basically, the company is paying for studies to use as talking points in Washington, D.C., hoping to stop new laws that would lower drug prices.

For more details, see rssapp-statnews-com at statnews.com/pharmalot/2026/05/22/genentech-soliciting-academics-write-papers-to-blunt-pharma-reforms-dc/ (opens in new tab)